đź“… 19th - 20th June 2025 đź“Ť Heathrow, London
Guardant Health
The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched the Guardant360® CDx and Guardant360® tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients.
Guardant Health aims to partner to address the needs of healthcare systems and individuals eligible for testing.
Email: clientserviceseurope@guardanthealth.com
Website: http://www.guardanthealth.co.uk
Guardant Health, Inc
3100 Hanover St
Palo Alto, CA 94304
United States